Home › Funds › PSP Research LLC › IONS

PSP Research LLC position in IONS

IONIS PHARMACEUTICALS INC COM · Health Care

PSP Research LLC reported holding 6,800 shares of IONS (IONIS PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$539K, representing 0.29% of its reported portfolio and ranking #14 among its reported holdings. PSP Research LLC has disclosed IONS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)6.80K sh
Reported value held$539.17K
Portfolio Weight0.29%
First reportedQ4 2025
Last changeNew

How PSP Research LLC's IONS position evolved

PSP Research LLC first disclosed a stake in IONS in Q4 2025 at 6,800 shares (US$538K). The position peaked in Q2 2026 at 6,800 shares, worth US$539K. Across 3 filings, PSP Research LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 6,800 shares valued at US$539K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 6.80K $537.95K New
Q1 2026 6.80K $510.61K Hold
Q2 2026 6.80K $539.17K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC COM) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →